Bart Ghesquiere Selected Research

ertugliflozin

11/2022

The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bart Ghesquiere Research Topics

Disease

4	Neoplasms (Cancer) 04/2024 - 01/2018
3	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 04/2024
1	Triple Negative Breast Neoplasms 12/2023
1	Cardiomegaly (Heart Hypertrophy) 11/2022
1	Fibrosis (Cirrhosis) 11/2022
1	Neuroblastoma 07/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	COVID-19 01/2021
1	Infections 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Lung Injury 01/2019
1	Acute Lung Injury 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Ischemia 01/2018
1	Inflammation (Inflammations) 09/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2021
2	EnzymesIBA 04/2024 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2018
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 04/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	Androgen Receptors (Androgen Receptor)IBA 04/2024
1	LipidsIBA 04/2024
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	ertugliflozinIBA 11/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022
1	SodiumIBA 11/2022
1	SymportersIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Sirolimus (Rapamycin)FDA Link 11/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	GlycogenIBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	CarbonIBA 01/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-13IBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Prolyl-Hydroxylase InhibitorsIBA 09/2017

Therapy/Procedure

3	Therapeutics 04/2024 - 01/2022
1	Drug Therapy (Chemotherapy) 12/2023